Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma.
about
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisEmergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: A meta-analysisPromoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients.Aberrant promoter CpG methylation and its translational applications in breast cancer.Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter.Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis.
P2860
Q33734287-1B656844-2E7B-4023-B26D-A9AFBA960DEBQ33739319-CCEC1411-BEE9-47E9-B8FA-CEC728CD5491Q33889555-0CF19AF2-6FEB-4390-853E-8D8182105B1DQ34284716-24A956A6-ED3F-4203-B47A-797150457A2FQ36334551-3A4B0773-EFFD-4F6E-B736-0C0895D676E3Q37060670-D5055506-93F9-4B71-890A-A852859B5D4EQ37354053-3BB40140-9210-4294-A8E1-F007B31E3EB6Q39525228-0E1FDECD-CD97-4ADC-9F3E-BC49CD81726BQ39533559-E404154C-948D-4953-A548-7576DCBAC397Q39533563-9D040746-283A-4F6B-AB6A-61CBC3AD143AQ42444119-F8E83071-CE19-4684-8A8E-491239E63770Q45848291-D9145CC4-D3F9-494E-8186-E0202A7E0E45Q46950071-B4F87CAC-2D1C-4DE2-9327-51B261F3C54E
P2860
Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical significance of epige ...... ith invasive breast carcinoma.
@en
Clinical significance of epige ...... ith invasive breast carcinoma.
@nl
type
label
Clinical significance of epige ...... ith invasive breast carcinoma.
@en
Clinical significance of epige ...... ith invasive breast carcinoma.
@nl
prefLabel
Clinical significance of epige ...... ith invasive breast carcinoma.
@en
Clinical significance of epige ...... ith invasive breast carcinoma.
@nl
P2093
P2860
P356
P1476
Clinical significance of epige ...... ith invasive breast carcinoma.
@en
P2093
Abdelmajid Khabir
Ali Gargouri
Fatma Trifa
Jamel Daoud
Mounir Frikha
Nouredine Boujelbane
Raja Mokdad-Gargouri
Sondes Karray-Chouayekh
Tahia Sellami-Boudawara
P2860
P304
P356
10.1155/2009/369129
P577
2009-07-29T00:00:00Z